Don’t let Retained Blood Syndrome block your patient’s recovery.
Developed by cardiothoracic surgeons,
PleuraFlow® Active Clearance Technology® (ACT)
proactively maintains drainage-catheter patency to ensure optimal evacuation of blood and fluids from the chest cavity. Now you can act early to confidently avoid post surgical fluid collection, the root cause of Retained Blood Syndrome (RBS).
Retained Blood Syndrome (RBS) is the composite of drainage-related complications after cardiothoracic surgery, including hemothorax, pericardial tamponade, bloody pleural or pericardial effusions. Retained Blood Syndrome (RBS) complications are detrimental to patient outcomes and may require early or late reinterventions to remediate.6, 16, 17
Retained Blood Syndrome (RBS) may result in postoperative atrial fibrillation (POAF), acute kidney injury and stroke.16REVIEW THE EVIDENCE
PleuraFlow ACT is a simple yet innovative technology that utilizes a magnetically driven Clearance Loop to proactively maintain flow. PleuraFlow ACT has been shown to substantially reduce Retained Blood Syndrome (RBS) reinterventions compared to conventional chest tubes16 and is easy to implement into your hospital’s Quality System as a Standard of Care.PLEURAFLOW ACT SUCCESS
ClearFlow is advocating the establishment of Standards and Guidelines to encourage active maintenance of chest tube patency in the first 24 hours post surgery. Why risk your patient’s recovery on a conventional chest tube? Join the fight to make Retained Blood Syndrome (RBS) a never event.Learn More